G Harrison

6.1k citations
30 papers · 4.6k · 2 hit papers · h-index 19

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

G Harrison

30 papers receiving 4.5k citations

G Harrison's Hit Papers

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials 2001 · 1.2k citations
1.2k0+9+18Years since publication50010001.5k2.0k

Peers

G Harrison
Comparison fields: 5 of 70
  • Hematology 3.8k
  • Genetics 821
  • Public Health, Environmental and Occupational Health 1.6k
  • Molecular Biology 1.4k
  • Oncology 441
Replace MM Le Beau with:
MM Le Beau United States
FG Behm United States
F G Behm United States
Lewis R. Silverman United States
Mårina Lafage‐Pochitaloff France
O. Margaret Garson Australia
Itsuro Jinnai Japan
S Yokota Japan
CD Bloomfield United States
Jan Trka Czechia
G Harrison relative to MM Le Beau United States MM Le Beau's profile →
Citations per field
00.5×7.9×
MM Le Beau · 1×
Citations per year

Countries citing papers authored by G Harrison

Since Specialization
Citations

This map shows the geographic impact of G Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Harrison more than expected).

Fields of papers citing papers by G Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Harrison. The network helps show where G Harrison may publish in the future.

Co-authors

The 25 scholars most cited alongside G Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G Harrison Line = papers co-authored together G Harrison links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
Hit paper breakdown →
19982096
2
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
Hit paper breakdown →
20011183
3 2002238
4 1997178
5 2001101
6 200198
7 200396
8 199993
9 199983
10 200272
11 199848
12 200142
13 199739
14 200230
15 200028
16 200327
17 199926
18
Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).
200121
19
Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993)
200121
20 200218

About G Harrison

G Harrison is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health, having authored 30 papers that have together received 4.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (23 papers), Acute Myeloid Leukemia Research (17 papers), Chronic Myeloid Leukemia Treatments (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Retinoids in leukemia and cellular processes (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (3.8k citations), Genetics (821 citations), Public Health, Environmental and Occupational Health (1.6k citations), Molecular Biology (1.4k citations) and Oncology (441 citations). G Harrison has collaborated with scholars based in United Kingdom, India and Greece. Frequent co-authors include Keith Wheatley, Alan K. Burnett, Helen M. Walker, Ian Hann, Richard Stevens, John Rees, Christine J. Harrison, David Grimwade, Anthony P. Goldstone and Fiona Oliver. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of Clinical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact